Table 4 Association of pretreatment serum interferon γ inducible protein 10 (IP‐10) with baseline characteristics of hepatitis C virus (HCV) patients.
| Variable | Serum IP‐10 levels (pg/ml)) | |||
|---|---|---|---|---|
| All HCV patients (n = 137) | p Value | Genotype 1 patients (n = 103) | p Value | |
| Sex | ||||
| Male | 348.5 (253.3) (n = 77) | 0.09 | 374.1 (265.2) (n = 64) | 0.07 |
| Female | 428.2 (277.6) (n = 60) | 458.5 (254.3) (n = 39) | ||
| HCV genotype | ||||
| 1 | 421.8 (266.2) (n = 103) | 0.04 | ||
| Non 1 | 304.1 (261.3) (n = 34) | |||
| Viral load | ||||
| Low | 365.9 (236.5) (n = 52) | 0.13 | 371.1 (214.3) (n = 37) | 0.08 |
| High | 414.5 (285.1) (n = 85) | 451.9 (291.5) (n = 66) | ||
| Grade score | ||||
| 0–6 | 362.9 (241.6) (n = 78) | 0.11 | 395.2±243.7 (n = 56) | 0.39 |
| 7–14 | 421.6 (283.1) (n = 59) | 425.6±275.9 (n = 47) | ||
| Stage score | ||||
| 0–3 | 353.6 (234.1) (n = 106) | 0.005 | 376.1 (239.5) (n = 78) | 0.02 |
| 4–6 | 510.7 (313.4) (n = 31) | 525.7 (292.1) (n = 25) | ||
Values are mean (SD).